Lombard Medical (EVAR.F) Stock Analysis & Winston Score
Lombard Medical is a medical device company that makes stents used to treat a dangerous condition called an abdominal aortic aneurysm, which is a bulge in the main blood vessel in the belly that can burst and become life-threatening. Its main product is the Aorfix stent graft, a flexible tube-like device that doctors insert into the blood vessel to hold it open and prevent rupture. The company sells primarily to hospitals and vascular surgeons in the United States and Europe. Lombard Medical earns revenue by selling its stent graft systems directly to hospitals on a per-procedure basis. The company is small, with limited commercial scale compared to larger rivals like Medtronic and Cook Medical, which dominate the aortic stent market. Its main competitive angle is Aorfix's ability to treat patients with unusually curved or angled arteries that other devices cannot easily handle, but the key risk is its narrow product portfolio and the financial pressure that comes with competing against much larger, better-funded companies.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Data not available (0/30)
- Growth: Data not available (0/20)
- Cash Flow: Data not available (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
